K
Kenneth A. Stauderman
Researcher at University of Cambridge
Publications - 59
Citations - 6953
Kenneth A. Stauderman is an academic researcher from University of Cambridge. The author has contributed to research in topics: Voltage-dependent calcium channel & Calcium. The author has an hindex of 24, co-authored 55 publications receiving 6537 citations. Previous affiliations of Kenneth A. Stauderman include Torrey Pines Institute for Molecular Studies.
Papers
More filters
Journal ArticleDOI
Characterization of the recombinant human neuronal nicotinic acetylcholine receptors α3β2 and α4β2 stably expressed in HEK293 cells
Laura E. Chavez-Noriega,Alison Gillespie,Kenneth A. Stauderman,James H. Crona,Brian O. Claeps,Kathryn J. Elliott,R. T. Reid,Tadimeti S. Rao,Gonul Velicelebi,Michael M. Harpold,Edwin C. Johnson,Janis Corey-Naeve +11 more
TL;DR: The results indicate that stably expressed α3β2 and α4β2 human nAChRs are pharmacologically and functionally distinct.
Journal ArticleDOI
The Orai Ca 2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis.
Richard T. Waldron,Richard T. Waldron,Richard T. Waldron,Yafeng Chen,Yafeng Chen,Hung Pham,Ariel Go,Hsin-Yuan Su,Cheng Hu,Li Wen,Li Wen,Sohail Z. Husain,Sohail Z. Husain,Catherine A. Sugar,Jack Roos,Stephanie Ramos,Aurelia Lugea,Aurelia Lugea,Aurelia Lugea,Michael J. Dunn,Kenneth A. Stauderman,Stephen J. Pandol,Stephen J. Pandol,Stephen J. Pandol +23 more
TL;DR: Im intravenous administration of CM4620 reduces the severity of acute pancreatitis in the rat, a hitherto untested species, and it is shown that SOCE via STIM1/Orai complexes promotes activation and fibroinflammatory gene expression within pancreatic stellate cells.
Journal ArticleDOI
Rat group I metabotropic glutamate receptors inhibit neuronal Ca2+ channels via multiple signal transduction pathways in HEK 293 cells.
Brian A. McCool,Jean-Phillipe Pin,Michael M. Harpold,Paul Brust,Kenneth A. Stauderman,David M. Lovinger +5 more
TL;DR: It is concluded that group I mGluRs can modulate neuronal Ca2+ channels using a variety of signal transduction pathways and proposed that the relative contributions of different pathways may exemplify the diversity of responses mediated by these receptors in the CNS.
Journal ArticleDOI
CRAC channels as targets for drug discovery and development.
TL;DR: The challenges associated with drug discovery and development on CRAC channels and the approaches employed to date are discussed, as well as the results, starting from initial high-throughput screens for CRAC channel modulators and progressing through target selection and justification, descriptions of pharmacological, safety and toxicological profiles of compounds, and finally the entry ofCRAC channel inhibitors into clinical trials.
Patent
Inhibitors of store operated calcium release
TL;DR: In this paper, compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels, are described and methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases, disorders or conditions that would benefit from inhibition of SOC channel activity.